United States Antidepressants Drugs Market Report 2017

November 2017 | 105 pages | ID: UFE2AABAB39WEN
QYResearch

Abstracts

In this report, the United States Antidepressants Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Antidepressants Drugs in these regions, from 2012 to 2022 (forecast).

United States Antidepressants Drugs market competition by top manufacturers/players, with Antidepressants Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• AstraZeneca
• Eli Lilly and Company
• Gedeon Richter
• GlaxoSmithKline
• Janssen Pharmaceuticals
• Lupin Pharmaceuticals
• Luye Pharma
• MSI Methylation Sciences
• Naurex
• Abbott Laboratories
• Novartis
• Otsuka Pharmaceutical
• SK Biopharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tricyclic Antidepressants
• Serotonin-norepinephrine Inhibitors
• Atypical Antipsychotics
• Selective Serotonin Reuptake Inhibitors
• Benzodiazepines
• Tetracyclic Antidepressants
• Monoamine Oxidase Inhibitors
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antidepressants Drugs for each application, including

• Clinics & Hospitals
• Research Centers

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Antidepressants Drugs Market Report 2017

1 ANTIDEPRESSANTS DRUGS OVERVIEW

1.1 Product Overview and Scope of Antidepressants Drugs
1.2 Classification of Antidepressants Drugs by Product Category
  1.2.1 United States Antidepressants Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Antidepressants Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Tricyclic Antidepressants
  1.2.4 Serotonin-norepinephrine Inhibitors
  1.2.5 Atypical Antipsychotics
  1.2.6 Selective Serotonin Reuptake Inhibitors
  1.2.7 Benzodiazepines
  1.2.8 Tetracyclic Antidepressants
  1.2.9 Monoamine Oxidase Inhibitors
  1.2.10 Others
1.3 United States Antidepressants Drugs Market by Application/End Users
  1.3.1 United States Antidepressants Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Clinics & Hospitals
  1.3.3 Research Centers
1.4 United States Antidepressants Drugs Market by Region
  1.4.1 United States Antidepressants Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Antidepressants Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Antidepressants Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Antidepressants Drugs Status and Prospect (2012-2022)
  1.4.5 New England Antidepressants Drugs Status and Prospect (2012-2022)
  1.4.6 The South Antidepressants Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Antidepressants Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antidepressants Drugs (2012-2022)
  1.5.1 United States Antidepressants Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Antidepressants Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES ANTIDEPRESSANTS DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Antidepressants Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antidepressants Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antidepressants Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Antidepressants Drugs Market Competitive Situation and Trends
  2.4.1 United States Antidepressants Drugs Market Concentration Rate
  2.4.2 United States Antidepressants Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antidepressants Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANTIDEPRESSANTS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Antidepressants Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Antidepressants Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Antidepressants Drugs Price by Region (2012-2017)

4 UNITED STATES ANTIDEPRESSANTS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Antidepressants Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antidepressants Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Antidepressants Drugs Price by Type (2012-2017)
4.4 United States Antidepressants Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ANTIDEPRESSANTS DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Antidepressants Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Antidepressants Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANTIDEPRESSANTS DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antidepressants Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Antidepressants Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.2 Antidepressants Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Antidepressants Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly and Company
  6.3.2 Antidepressants Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly and Company Antidepressants Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Gedeon Richter
  6.4.2 Antidepressants Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Gedeon Richter Antidepressants Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline
  6.5.2 Antidepressants Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Antidepressants Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Janssen Pharmaceuticals
  6.6.2 Antidepressants Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Janssen Pharmaceuticals Antidepressants Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Lupin Pharmaceuticals
  6.7.2 Antidepressants Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Lupin Pharmaceuticals Antidepressants Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Luye Pharma
  6.8.2 Antidepressants Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Luye Pharma Antidepressants Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 MSI Methylation Sciences
  6.9.2 Antidepressants Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 MSI Methylation Sciences Antidepressants Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Naurex
  6.10.2 Antidepressants Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Naurex Antidepressants Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Abbott Laboratories
6.12 Novartis
6.13 Otsuka Pharmaceutical
6.14 SK Biopharmaceuticals

7 ANTIDEPRESSANTS DRUGS MANUFACTURING COST ANALYSIS

7.1 Antidepressants Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antidepressants Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antidepressants Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antidepressants Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANTIDEPRESSANTS DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Antidepressants Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antidepressants Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Antidepressants Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Antidepressants Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antidepressants Drugs
Figure United States Antidepressants Drugs Market Size (K Units) by Type (2012-2022)
Figure United States Antidepressants Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Tricyclic Antidepressants Product Picture
Figure Serotonin-norepinephrine Inhibitors Product Picture
Figure Atypical Antipsychotics Product Picture
Figure Selective Serotonin Reuptake Inhibitors Product Picture
Figure Benzodiazepines Product Picture
Figure Tetracyclic Antidepressants Product Picture
Figure Monoamine Oxidase Inhibitors Product Picture
Figure Others Product Picture
Figure United States Antidepressants Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Antidepressants Drugs by Application in 2016
Figure Clinics & Hospitals Examples
Table Key Downstream Customer in Clinics & Hospitals
Figure Research Centers Examples
Table Key Downstream Customer in Research Centers
Figure United States Antidepressants Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Antidepressants Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antidepressants Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antidepressants Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antidepressants Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antidepressants Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antidepressants Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antidepressants Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States Antidepressants Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antidepressants Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Antidepressants Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Antidepressants Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antidepressants Drugs Sales Share by Players/Suppliers
Figure 2017 United States Antidepressants Drugs Sales Share by Players/Suppliers
Figure United States Antidepressants Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antidepressants Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antidepressants Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antidepressants Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Antidepressants Drugs Revenue Share by Players/Suppliers
Table United States Market Antidepressants Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Antidepressants Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Antidepressants Drugs Market Share of Top 3 Players/Suppliers
Figure United States Antidepressants Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antidepressants Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antidepressants Drugs Product Category
Table United States Antidepressants Drugs Sales (K Units) by Region (2012-2017)
Table United States Antidepressants Drugs Sales Share by Region (2012-2017)
Figure United States Antidepressants Drugs Sales Share by Region (2012-2017)
Figure United States Antidepressants Drugs Sales Market Share by Region in 2016
Table United States Antidepressants Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antidepressants Drugs Revenue Share by Region (2012-2017)
Figure United States Antidepressants Drugs Revenue Market Share by Region (2012-2017)
Figure United States Antidepressants Drugs Revenue Market Share by Region in 2016
Table United States Antidepressants Drugs Price (USD/Unit) by Region (2012-2017)
Table United States Antidepressants Drugs Sales (K Units) by Type (2012-2017)
Table United States Antidepressants Drugs Sales Share by Type (2012-2017)
Figure United States Antidepressants Drugs Sales Share by Type (2012-2017)
Figure United States Antidepressants Drugs Sales Market Share by Type in 2016
Table United States Antidepressants Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antidepressants Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antidepressants Drugs by Type (2012-2017)
Figure Revenue Market Share of Antidepressants Drugs by Type in 2016
Table United States Antidepressants Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States Antidepressants Drugs Sales Growth Rate by Type (2012-2017)
Table United States Antidepressants Drugs Sales (K Units) by Application (2012-2017)
Table United States Antidepressants Drugs Sales Market Share by Application (2012-2017)
Figure United States Antidepressants Drugs Sales Market Share by Application (2012-2017)
Figure United States Antidepressants Drugs Sales Market Share by Application in 2016
Table United States Antidepressants Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Antidepressants Drugs Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Antidepressants Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Antidepressants Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Antidepressants Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Antidepressants Drugs Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Antidepressants Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Antidepressants Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Antidepressants Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca Antidepressants Drugs Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Antidepressants Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Antidepressants Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Antidepressants Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Antidepressants Drugs Revenue Market Share in United States (2012-2017)
Table Gedeon Richter Basic Information List
Table Gedeon Richter Antidepressants Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gedeon Richter Antidepressants Drugs Sales Growth Rate (2012-2017)
Figure Gedeon Richter Antidepressants Drugs Sales Market Share in United States (2012-2017)
Figure Gedeon Richter Antidepressants Drugs Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antidepressants Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Antidepressants Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Antidepressants Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Antidepressants Drugs Revenue Market Share in United States (2012-2017)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Antidepressants Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals Antidepressants Drugs Sales Growth Rate (2012-2017)
Figure Janssen Pharmaceuticals Antidepressants Drugs Sales Market Share in United States (2012-2017)
Figure Janssen Pharmaceuticals Antidepressants Drugs Revenue Market Share in United States (2012-2017)
Table Lupin Pharmaceuticals Basic Information List
Table Lupin Pharmaceuticals Antidepressants Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lupin Pharmaceuticals Antidepressants Drugs Sales Growth Rate (2012-2017)
Figure Lupin Pharmaceuticals Antidepressants Drugs Sales Market Share in United States (2012-2017)
Figure Lupin Pharmaceuticals Antidepressants Drugs Revenue Market Share in United States (2012-2017)
Table Luye Pharma Basic Information List
Table Luye Pharma Antidepressants Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Luye Pharma Antidepressants Drugs Sales Growth Rate (2012-2017)
Figure Luye Pharma Antidepressants Drugs Sales Market Share in United States (2012-2017)
Figure Luye Pharma Antidepressants Drugs Revenue Market Share in United States (2012-2017)
Table MSI Methylation Sciences Basic Information List
Table MSI Methylation Sciences Antidepressants Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MSI Methylation Sciences Antidepressants Drugs Sales Growth Rate (2012-2017)
Figure MSI Methylation Sciences Antidepressants Drugs Sales Market Share in United States (2012-2017)
Figure MSI Methylation Sciences Antidepressants Drugs Revenue Market Share in United States (2012-2017)
Table Naurex Basic Information List
Table Naurex Antidepressants Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Naurex Antidepressants Drugs Sales Growth Rate (2012-2017)
Figure Naurex Antidepressants Drugs Sales Market Share in United States (2012-2017)
Figure Naurex Antidepressants Drugs Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Novartis Basic Information List
Table Otsuka Pharmaceutical Basic Information List
Table SK Biopharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidepressants Drugs
Figure Manufacturing Process Analysis of Antidepressants Drugs
Figure Antidepressants Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antidepressants Drugs Major Players/Suppliers in 2016
Table Major Buyers of Antidepressants Drugs
Table Distributors/Traders List
Figure United States Antidepressants Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Antidepressants Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antidepressants Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Antidepressants Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Antidepressants Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Antidepressants Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States Antidepressants Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Antidepressants Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Antidepressants Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States Antidepressants Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Antidepressants Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antidepressants Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antidepressants Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources